• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期亨廷顿舞蹈病中的苯二氮䓬类药物与γ-氨基丁酸受体

Benzodiazepine and GABA receptors in early Huntington's disease.

作者信息

Walker F O, Young A B, Penney J B, Dovorini-Zis K, Shoulson I

出版信息

Neurology. 1984 Sep;34(9):1237-40. doi: 10.1212/wnl.34.9.1237.

DOI:10.1212/wnl.34.9.1237
PMID:6087209
Abstract

We compared autoradiographic measurements of GABA and benzodiazepine receptors in the brains of two early cases of Huntington's disease (HD), five controls, and four advanced cases of HD. These receptors increase in lateral globus pallidus and decrease in putamen early in the disease, before there is any extensive cell loss and atrophy. The cause of these receptor changes is unknown, but could imply dysfunction rather than death of striatal neurons.

摘要

我们比较了2例早期亨廷顿舞蹈症(HD)患者、5例对照者以及4例晚期HD患者大脑中γ-氨基丁酸(GABA)和苯二氮䓬受体的放射自显影测量结果。在疾病早期,在出现广泛细胞丢失和萎缩之前,这些受体在外侧苍白球中增加,而在壳核中减少。这些受体变化的原因尚不清楚,但可能意味着纹状体神经元功能障碍而非死亡。

相似文献

1
Benzodiazepine and GABA receptors in early Huntington's disease.早期亨廷顿舞蹈病中的苯二氮䓬类药物与γ-氨基丁酸受体
Neurology. 1984 Sep;34(9):1237-40. doi: 10.1212/wnl.34.9.1237.
2
Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.亨廷顿舞蹈病患者苍白球中大麻素(CB(1))、γ-氨基丁酸A(GABA(A))和γ-氨基丁酸B(GABA(B))受体亚基的变化
J Chem Neuroanat. 2009 Jul;37(4):266-81. doi: 10.1016/j.jchemneu.2009.02.001. Epub 2009 Feb 21.
3
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.亨廷顿舞蹈病中的神经退行性变模式:亨廷顿舞蹈病患者人类基底神经节中大麻素、多巴胺、腺苷和GABA(A)受体改变的比较研究
Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7.
4
Neurochemical substrates of rigidity and chorea in Huntington's disease.亨廷顿舞蹈症中强直与舞蹈症的神经化学底物
Brain. 1993 Oct;116 ( Pt 5):1201-22. doi: 10.1093/brain/116.5.1201.
5
Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.亨廷顿舞蹈病中的神经递质受体改变:放射自显影和匀浆研究,特别涉及苯二氮䓬受体复合物
Ann Neurol. 1985 Aug;18(2):202-10. doi: 10.1002/ana.410180207.
6
Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.亨廷顿舞蹈病大脑中谷氨酸减少,5-羟色胺增加。
Neurosci Lett. 1987 Jul 22;78(2):233-8. doi: 10.1016/0304-3940(87)90639-2.
7
NMDA receptor losses in putamen from patients with Huntington's disease.亨廷顿病患者壳核中的N-甲基-D-天冬氨酸受体缺失
Science. 1988 Aug 19;241(4868):981-3. doi: 10.1126/science.2841762.
8
GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects.亨廷顿舞蹈症患者及对照者大脑中的γ-氨基丁酸含量和谷氨酸脱羧酶活性
J Neurochem. 1975 May;24(5):1071-5. doi: 10.1111/j.1471-4159.1975.tb03679.x.
9
Increase in diazepam binding inhibitor-like immunoreactivity (51-70) in Huntington's disease.亨廷顿舞蹈症中地西泮结合抑制剂样免疫反应性(51-70)增加。
J Neurol Sci. 1988 Dec;88(1-3):177-84. doi: 10.1016/0022-510x(88)90215-8.
10
Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.正电子发射断层扫描术对亨廷顿舞蹈症中苯二氮䓬受体的测量
Ann Neurol. 1993 Jul;34(1):76-81. doi: 10.1002/ana.410340114.

引用本文的文献

1
Cellular basis of learning and memory in the carotid body.颈动脉体学习与记忆的细胞基础。
Front Synaptic Neurosci. 2022 Aug 15;14:902319. doi: 10.3389/fnsyn.2022.902319. eCollection 2022.
2
Insights into GABAergic system alteration in Huntington's disease.对亨廷顿病中 GABA 能系统改变的深入了解。
Open Biol. 2018 Dec 5;8(12):180165. doi: 10.1098/rsob.180165.
3
Disrupted striatal neuron inputs and outputs in Huntington's disease.亨廷顿病中纹状体神经元输入和输出的紊乱。
CNS Neurosci Ther. 2018 Apr;24(4):250-280. doi: 10.1111/cns.12844.
4
Alteration of GABAergic neurotransmission in Huntington's disease.亨廷顿病中 GABA 能神经递质的改变。
CNS Neurosci Ther. 2018 Apr;24(4):292-300. doi: 10.1111/cns.12826. Epub 2018 Feb 21.
5
Genetics and neuropathology of Huntington's disease.亨廷顿病的遗传学和神经病理学。
Int Rev Neurobiol. 2011;98:325-72. doi: 10.1016/B978-0-12-381328-2.00014-6.
6
Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.在多聚谷氨酰胺诱导的运动神经元变性中,动力蛋白激活蛋白1介导的逆行轴突运输的可逆性破坏。
J Neurosci. 2006 Nov 22;26(47):12106-17. doi: 10.1523/JNEUROSCI.3032-06.2006.
7
Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.用[(123)I]奥氮平及单光子发射计算机断层扫描定量检测亨廷顿病中的苯二氮䓬受体
J Neurol Neurosurg Psychiatry. 2001 May;70(5):657-61. doi: 10.1136/jnnp.70.5.657.
8
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.亨廷顿舞蹈症转基因小鼠模型中神经递质受体表达的改变
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):981-9. doi: 10.1098/rstb.1999.0449.
9
Visualizing receptors for neurotransmitters in the human brain with autoradiography.利用放射自显影技术观察人类大脑中神经递质的受体。
Neurosurg Rev. 1989;12(1):11-20. doi: 10.1007/BF01787120.
10
Differential loss of striatal projection neurons in Huntington disease.亨廷顿病中纹状体投射神经元的差异性丢失
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5733-7. doi: 10.1073/pnas.85.15.5733.